Abzu discovered key biomarkers for successful clinical trial of siRNA therapeutic.
Simple models accurately predicted and explained key biomarkers for successful clinical trial test of siRNA designed to downregulate.
Abzu is named a 2022 Gartner “Cool Vendor”.
We’re thrilled to announce that Gartner has named Abzu a “Cool Vendor” in AI for excelling in explainability, fairness, and trustworthiness.